These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients. Kan WC, Chien CC, Wu CC, Su SB, Hwang JC, Wang HY. Nephrol Dial Transplant; 2010 May; 25(5):1604-8. PubMed ID: 19948879 [Abstract] [Full Text] [Related]
7. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin]. Kalinowski M, Popławski A, Kaliszewski Z, Juzwiuk J. Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931 [Abstract] [Full Text] [Related]
14. Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication. Short AI, Winney RJ, Robson JS. Proc Eur Dial Transplant Assoc; 1980 Jan; 17():226-33. PubMed ID: 7243773 [Abstract] [Full Text] [Related]
15. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy. Abreo K, Brown ST, Sella M, Trapp G. J Lab Clin Med; 1989 Jan; 113(1):50-7. PubMed ID: 2909650 [Abstract] [Full Text] [Related]